1. pinkiemeck
2. buzzandbuzzhead
1.pinkiemeck 03/09/2018
Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, O…
2.buzzandbuzzhead 03/09/2018
Beats EPS loss estimates by $0.20
3.pinkiemeck 02/14/2018
MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW